| Location |
Symbol |
Title |
MIM # |
Disorder |
Comments |
Method |
Mouse |
| 11pter-p15.5 |
ALG8 |
Alg8, S. cerevisiae, homolog of |
608103 |
Congenital disorder of glycosylation, type Ih, 608104 (3) |
|
REc |
|
| 11pter-p15.5 |
RRAS2, TC21 |
Related Ras viral oncogene homolog 2 |
600098 |
Ovarian carcinoma (3) |
|
R |
|
| 11pter-p13 |
AMPD3 |
Adenosine monophosphate deaminase-3, isoform E |
102772 |
[AMP deaminase deficiency, erythrocytic], 612874 (3) |
|
REa |
7(Ampd3) |
| 11pter-p13 |
CD44, MDU2, MDU3, MIC4 |
CD44 antigen (homing function) |
107269 |
[Blood group, Indian system] (3) |
|
S |
2(Ly24) |
| 11pter-p11.2 |
TP250 |
T-cell activation antigen p250 |
186710 |
|
|
S |
|
| 11p15.5 |
AP2A2, KIAA0899 |
Adaptor-related protein complex 2, alpha-2 subunit |
607242 |
|
|
R, REc |
|
| 11p15.5 |
ASCL2 |
Achaete-scute complex, Drosophila, homolog-like 2 |
601886 |
|
|
A |
|
| 11p15.5 |
BM88 |
BM88 antigen |
608213 |
|
|
REc, A |
|
| 11p15.5 |
C11orf13, HRC1 |
HRAS1-related cluster-1 |
143023 |
|
29kb 5' to HRAS1; divergently transcribed |
REn |
|
| 11p15.5 |
C11orf21 |
Chromosome 11 open reading frame 21 |
611033 |
|
|
REc |
|
| 11p15.5 |
CARS |
Cysteinyl-tRNA synthetase |
123859 |
|
|
REa, A |
|
| 11p15.5 |
CD151, PETA3, SFA1, MER2 |
CD151 antigen |
602243 |
Nephropathy with pretibial epidermolysis bullosa and deafness,609057 (3); [Blood group, Raph], 179620 (3) |
|
A, S, REa |
|
| 11p15.5 |
CDKN1C, KIP2, BWS |
Cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
600856 |
Beckwith-Wiedemann syndrome, 130650 (3) |
rare cause of BWS |
A, Ch, Fd |
7(Kip2) |
| 11p15.5 |
CHRNA10 |
Cholinergic receptor, neuronal nicotinic, alpha polypeptide 10 |
606372 |
|
|
A, R |
|
| 11p15.5 |
CTSD, CPSD, CLN10 |
Cathepsin D (lysosomal aspartyl protease) |
116840 |
Ceroid lipofuscinosis, neuronal, 10, 610127 (3) |
|
REa, A |
|
| 11p15.5 |
DRD4 |
Dopamine receptor D4 |
126452 |
Autonomic nervous system dysfunction (3); [Novelty seekingpersonality], 601696 (1); {Attention deficit-hyperactivity disorder}, 143465 (3); {Parkinson disease, protection against}, 168600 (3) |
proximal to HRAS |
Fd |
|
| 11p15.5 |
DUSP8, HVH8 |
Dual specificity phosphatase-8 |
602038 |
|
pseudogene on 10q11.2 |
A |
7(Dusp8) |
| 11p15.5 |
H19, D11S813E, ASM1, BWS, WT2 |
H19 gene |
103280 |
Beckwith-Wiedemann syndrome, 130650 (3); Silver-Russell syndrome,180860 (3); Wilms tumor 2, 194071 (3) |
same 200kb fragment as IGF2 |
REa, A, RE |
7(H19) |
| 11p15.5 |
HCCA2 |
HCCA2 gene |
611969 |
|
|
REc |
|
| 11p15.5 |
IDDM2 |
Insulin-dependent diabetes mellitus-2 |
125852 |
{Diabetes mellitus, insulin-dependent, 2} (2) |
|
Fd |
|
| 11p15.5 |
KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2 |
Potassium voltage-gated channel, KQT-like subfamily, member 1 |
607542 |
Long QT syndrome-1, 192500 (3); Jervell and Lange-Nielsen syndrome,220400 (3); Atrial fibrillation, familial, 3, 607554 (3); Torsades de pointes, drug-associated (3); Short QT syndrome-2, 609621 (3) |
|
Fd |
7(Kcnq1) |